Agency Information Collection Activities Under Emergency Review by the Office of Management and Budget, 43945-43946 [E8-17336]
Download as PDF
Federal Register / Vol. 73, No. 146 / Tuesday, July 29, 2008 / Notices
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism, Special
Emphasis Panel, Review of Specialized (P50)
and Comprehensive (P60) Alcohol Research
Centers.
Date: August 26, 2008.
Time: 1:30 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Alcohol Abuse
and Alcoholism, National Institutes of
Health, 5365 Fishers Lane, Rockville, MD
20852 (Telephone Conference Call).
Contact Person: Abraham P. Bautista, PhD,
Chief, Extramural Project Review Branch,
National Institute on Alcohol Abuse &
Alcoholism, National Institutes of Health,
5635 Fishers Lane, Rm. 3039, Rockville, MD
20852, 301–443–9737,
bautista@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants,
National Institutes of Health, HHS)
Dated: July 18, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–17167 Filed 7–28–08; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
jlentini on PROD1PC65 with NOTICES
National Library of Medicine; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The portions of the meeting devoted
to the review and evaluation of journals
for potential indexing by the National
Library of Medicine will be closed to the
public in accordance with the
provisions set forth in section
552b(c)(9)(B), Title 5 U.S.C., as
amended. Premature disclosure of the
VerDate Aug<31>2005
16:12 Jul 28, 2008
Jkt 214001
titles of the journals as potential titles to
be indexed by the National Library of
Medicine, the discussions, and the
presence of individuals associated with
these publications could significantly
frustrate the review and evaluation of
individual journals.
Name of Committee: Literature Selection
Technical Review Committee.
Date: October 23–24, 2008.
Open: October 23, 2008, 9 a.m. to 11 a.m.
Agenda: Administrative reports and
program discussion.
Place: National Library of Medicine,
Building 38, Board Room, 2 Floor, 8600
Rockville Pike, Bethesda, MD 20894.
Closed: October 23, 2008, 11 a.m. to 5 p.m.
Agenda: To review and evaluate journals
as potential titles to be indexed by the
National Library of Medicine.
Place: National Library of Medicine,
Building 38, Board Room, 2nd Floor, 8600
Rockville Pike, Bethesda, MD 20894.
Closed: October 24, 2008, 8:30 a.m. to 2
p.m.
Agenda: To review and evaluate journals
as potential titles to be indexed by the
National Library of Medicine.
Place: National Library of Medicine,
Building 38, Board Room, 2nd Floor, 8600
Rockville Pike, Bethesda, MD 20894.
Contact Person: Sheldon Kotzin, MLS,
Associate Director, Division of Library
Operations, National Library of Medicine,
8600 Rockville Pike, Bldg 38/Room 2W06,
Bethesda, MD 20894, 301–496–6921,
Sheldon Kotzin@nlm.nih.gov.
Any interested person may file written
comments with the Committee by forwarding
the statement to the Contact Person listed on
this Notice. The statement should include the
name, address, telephone number and, when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
into the building by nongovernment
employees. Persons without a government ID.
will need to show a photo ID. and sign in at
the security desk upon entering the building.
(Catalogue of Federal Domestic Assistance
Program No. 93.879, Medical Library
Assistance, National Institutes of Health,
HHS)
Dated: July 18, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy, NIH.
[FR Doc. E8–17044 Filed 7–28–08; 8:45 am]
BILLING CODE 4140–01–M
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
43945
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities Under Emergency Review by
the Office of Management and Budget
The Substance Abuse and Mental
Health Services Administration
(SAMHSA) has submitted the following
request (see below) for emergency OMB
review under the Paperwork Reduction
Act (44 U.S.C. Chapter 35). OMB
approval has been requested by August
8, 2008. A copy of the information
collection plans may be obtained by
calling the SAMHSA Reports Clearance
Officer on (240) 276–1243.
Title: Minority AIDS Initiative for
Collaboration for Prevention and
Treatment Improvement for American
Indians and Alaska Natives at Risk for
Substance Use and HIV/AID, (MIA)
Rapid HIV Testing Clinical Information
Form—NEW.
OMB Number: 0930–New.
Frequency: One-time-only
Affected Public: Tribes, Non-Profit
Tribal Organization and Urban Indian
Health Centers.
The Substance Abuse and Mental
Health Services Administration’s
(SAMHSA) Center Substance Abuse
Treatment (CSAT), is requesting an
emergency OMB review and approval of
the Minority AIDS Initiative for
Collaboration for Prevention and
Treatment Improvement for American
Indians and Alaska Natives at Risk for
Substance Use and HIV/AID, (MIA)
Rapid HIV Testing Clinical Information
Form. The MAI HIV Rapid Testing
Clinical Information Form would allow
SAMHSA/CSAT to collect essential
clinical information that will be used for
quality assurance, quality performance,
and product monitoring on
approximately 50,000 Rapid HIV Test
Kits to be provided to American Indian
and Alaska Native (AI/AN) communities
at no cost to the recipient provider
organizations. This Program is
authorized under section 509 of the
Public Health Service (PHs) Act [42
U.S.C. 290bb–2] .
The purpose of the MAI is to increase
HIV/Screening to American Indians and
Alaska Natives at risk for substance use
and thus HIV/AIDS in 13 States; build
and or strengthen tribes, tribal
organizations and urban Indian health
centers capacity to provide HIV/AIDS
education and prevention services to
American Indians and Alaska Natives;
reduce the stigma associated with HIV/
AIDS screening through outreach and
E:\FR\FM\29JYN1.SGM
29JYN1
43946
Federal Register / Vol. 73, No. 146 / Tuesday, July 29, 2008 / Notices
education and increase the number of
American Indians and Alaska Natives
who know their HIV/AIDS status.
The target population for the initiative
is tribes, tribal organizations, and urban
Indian organizations that reside in
Alaska, Arizona, California, Florida,
Michigan, Nevada, New Mexico, New
York, North Carolina, Oklahoma, Texas,
Utah and Washington who are at risk for
substance use and HIV/AIDS. The
selected states are those with the highest
concentration of AI/AN population
based on United States Census 2000. It
should be noted that 6 of these states
(California, Florida, Nevada, North
Carolina, and New York) are also
designated Block Grant HIV State-aside
states (reported 10 HIV cases per
100,000 to CDC). Additionally, the top
five AI/AN AIDS Case states are—
California, Oklahoma, Washington,
Arizona and Alaska, which also are part
of the target population.
Given the history, SAMHSA could not
have anticipated the need for the MAI
Rapid HIV Testing Clinical Information
Form earlier and is requesting an
emergency OMB approval. Due to the
six month shelf-life of the Rapid HIV
Test Kits it is unlikely that SAMHSA
will be able to distribute the kits and
collect the essential clinical information
prior to the expiration of the existing
20,000 Rapid HIV Test Kits without the
emergency OMB approval. Emergency
OMB approval will make available the
immediate distribution of up to 50,000
no cost Rapid HIV Test kits to American
Indian and Alaska Native communities.
The MAI Rapid HIV Testing Clinical
Information Form would support
quality of care, provide minimum but
adequate clinical and product
monitoring, and provide appropriate
safeguards against fraud, waste and
abuse of Federal funds. SAMHSA’s
approach would avoid unnecessary
delay in informing any person
potentially adversely affected by a test
kit recall or public health advisory.
The following table is the estimated
hour burden:
Number of respondents
Responses/
respondent
Burden hours
Total burden
hours
50,000 ..........................................................................................................................................
1
.167
8,350
Written comments and
recommendations concerning the
proposed information collection should
be sent within 30 Days of this notice to:
John Kraemer, Human Resources and
Housing Branch, Office of Management
and Budget, New Executive Office
Building, Room 10235, Washington, DC
20503; due to potential delays in OMB’s
receipt and processing of mail sent
through the U.S. Postal Service,
respondents are encouraged to submit
comments by fax to: 202–395–6974.
Date: July 24, 2008.
Christine Chen,
Director, Division of Grants Management.
[FR Doc. E8–17336 Filed 7–28–08; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HOMELAND
SECURITY
Office of Health Affairs; BioWatch
Filter Holder Log
Office of Health Affairs,
Weapons of Mass Destruction (WMD)
and Biodefense, Chem/Bio Early
Detection Division, DHS.
ACTION: 30-Day Notice and request for
comments; New Information Collection
Request 1601–NEW.
jlentini on PROD1PC65 with NOTICES
AGENCY:
SUMMARY: The Department of Homeland
Security, Office of Health Affairs, WMD
and Biodefense, has submitted the
following information collection request
(ICR) to the Office of Management and
Budget (OMB) for review and clearance
in accordance with the Paperwork
Reduction Act of 1995 (Pub. L. 104–13,
44 U.S.C. Chapter 35). The Office of
Health Affairs, WMD and Biodefense are
VerDate Aug<31>2005
16:12 Jul 28, 2008
Jkt 214001
soliciting comments concerning a new
information collection request, Bio
Watch Filter Holder Log Form 9500.
DHS previously published this
information collection request (ICR) in
the Federal Register on April 4, 2008 at
73 FR 18542, for a 60-day public
comment period. No comments were
received by DHS. The purpose of this
notice is to allow additional 30-days for
public comments.
DATES: Comments are encouraged and
will be accepted until August 28, 2008.
This process is conducted in accordance
with 5 CFR 1320.1.
ADDRESSES: Interested persons are
invited to submit written comments on
the proposed information collection to
the Office of Information and Regulatory
Affairs, Office of Management and
Budget. Comments should be addressed
to OMB Desk Officer for the Department
of Homeland Security, Office of Health
Affairs, and sent via electronic mail to
oira_submission@omb.eop.gov or faxed
to (202) 395–6974.
The Office of Management and Budget
is particularly interested in comments
which:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
FOR FURTHER INFORMATION CONTACT: If
additional information is required
contact: the Department of Homeland
Security, Office of Health Affairs, WMD
and Biodefense, Chem/Bio Early
Detection Division, Washington, DC
20528. Attn: Division Director, Dr.
Jeffrey Stiefel, 703–647–8056 or 202–
254–6076.
SUPPLEMENTARY INFORMATION: The
Department of Homeland Security
(DHS), Office of Health Affairs, WMD
and Biodefense, Chem/Bio Early
Detection Division requires the
collection of information by BioWatch
jurisdictions. The BioWatch Program
operates aerosol collector equipment in
approximately 30 U.S. jurisdictions to
monitor for the presence of organisms
that may be related to the deliberate
release of a select subset of biological
threat agents. Information is collected in
writing by a representative of a
BioWatch jurisdiction (either an
employee, or a contractor) responsible
for installing and removing filters from
aerosol collection devices and
transporting them to local laboratories
for sample analysis. A standard filter
holder log is completed for each sample
and is archived by the BioWatch
jurisdiction for a year. The DHS
BioWatch Program provides financial
support to the participating jurisdictions
E:\FR\FM\29JYN1.SGM
29JYN1
Agencies
[Federal Register Volume 73, Number 146 (Tuesday, July 29, 2008)]
[Notices]
[Pages 43945-43946]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-17336]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities Under Emergency Review
by the Office of Management and Budget
The Substance Abuse and Mental Health Services Administration
(SAMHSA) has submitted the following request (see below) for emergency
OMB review under the Paperwork Reduction Act (44 U.S.C. Chapter 35).
OMB approval has been requested by August 8, 2008. A copy of the
information collection plans may be obtained by calling the SAMHSA
Reports Clearance Officer on (240) 276-1243.
Title: Minority AIDS Initiative for Collaboration for Prevention
and Treatment Improvement for American Indians and Alaska Natives at
Risk for Substance Use and HIV/AID, (MIA) Rapid HIV Testing Clinical
Information Form--NEW.
OMB Number: 0930-New.
Frequency: One-time-only
Affected Public: Tribes, Non-Profit Tribal Organization and Urban
Indian Health Centers.
The Substance Abuse and Mental Health Services Administration's
(SAMHSA) Center Substance Abuse Treatment (CSAT), is requesting an
emergency OMB review and approval of the Minority AIDS Initiative for
Collaboration for Prevention and Treatment Improvement for American
Indians and Alaska Natives at Risk for Substance Use and HIV/AID, (MIA)
Rapid HIV Testing Clinical Information Form. The MAI HIV Rapid Testing
Clinical Information Form would allow SAMHSA/CSAT to collect essential
clinical information that will be used for quality assurance, quality
performance, and product monitoring on approximately 50,000 Rapid HIV
Test Kits to be provided to American Indian and Alaska Native (AI/AN)
communities at no cost to the recipient provider organizations. This
Program is authorized under section 509 of the Public Health Service
(PHs) Act [42 U.S.C. 290bb-2] .
The purpose of the MAI is to increase HIV/Screening to American
Indians and Alaska Natives at risk for substance use and thus HIV/AIDS
in 13 States; build and or strengthen tribes, tribal organizations and
urban Indian health centers capacity to provide HIV/AIDS education and
prevention services to American Indians and Alaska Natives; reduce the
stigma associated with HIV/AIDS screening through outreach and
[[Page 43946]]
education and increase the number of American Indians and Alaska
Natives who know their HIV/AIDS status.
The target population for the initiative is tribes, tribal
organizations, and urban Indian organizations that reside in Alaska,
Arizona, California, Florida, Michigan, Nevada, New Mexico, New York,
North Carolina, Oklahoma, Texas, Utah and Washington who are at risk
for substance use and HIV/AIDS. The selected states are those with the
highest concentration of AI/AN population based on United States Census
2000. It should be noted that 6 of these states (California, Florida,
Nevada, North Carolina, and New York) are also designated Block Grant
HIV State-aside states (reported 10 HIV cases per 100,000 to CDC).
Additionally, the top five AI/AN AIDS Case states are--California,
Oklahoma, Washington, Arizona and Alaska, which also are part of the
target population.
Given the history, SAMHSA could not have anticipated the need for
the MAI Rapid HIV Testing Clinical Information Form earlier and is
requesting an emergency OMB approval. Due to the six month shelf-life
of the Rapid HIV Test Kits it is unlikely that SAMHSA will be able to
distribute the kits and collect the essential clinical information
prior to the expiration of the existing 20,000 Rapid HIV Test Kits
without the emergency OMB approval. Emergency OMB approval will make
available the immediate distribution of up to 50,000 no cost Rapid HIV
Test kits to American Indian and Alaska Native communities. The MAI
Rapid HIV Testing Clinical Information Form would support quality of
care, provide minimum but adequate clinical and product monitoring, and
provide appropriate safeguards against fraud, waste and abuse of
Federal funds. SAMHSA's approach would avoid unnecessary delay in
informing any person potentially adversely affected by a test kit
recall or public health advisory.
The following table is the estimated hour burden:
----------------------------------------------------------------------------------------------------------------
Responses/ Total burden
Number of respondents respondent Burden hours hours
----------------------------------------------------------------------------------------------------------------
50,000....................................................... 1 .167 8,350
----------------------------------------------------------------------------------------------------------------
Written comments and recommendations concerning the proposed
information collection should be sent within 30 Days of this notice to:
John Kraemer, Human Resources and Housing Branch, Office of Management
and Budget, New Executive Office Building, Room 10235, Washington, DC
20503; due to potential delays in OMB's receipt and processing of mail
sent through the U.S. Postal Service, respondents are encouraged to
submit comments by fax to: 202-395-6974.
Date: July 24, 2008.
Christine Chen,
Director, Division of Grants Management.
[FR Doc. E8-17336 Filed 7-28-08; 8:45 am]
BILLING CODE 4162-20-P